CRESCENT BIOPHARMA, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 09/19/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $10.8 | — | — | $<0.1 | $0.1 |
| Operating income | -$152.6 | -$40.0 | — | -$39.3 | -$47.4 |
| Net income | -$153.9 | -$37.9 | — | -$36.9 | -$46.7 |
| Cash Flow Statement | |||||
| Free cash flow | -$72.5 | -$31.1 | — | -$34.9 | -$46.5 |
| Share repurchases | $0.2 | — | — | — | — |
Shares outstanding 37.1M · Free float 19.8%
Annual filing data through FY ended December 31, 2025; float as of September 27, 2026.